ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
23.081,03
3,37%
S&P 500
5.842,63
1,12%
Dow Jones
43.006,59
1,14%
Euro vs US Dollar
1,08008
0,06%
Bitcoin
91.727,18
1,19%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Serina Therapeutics Inc (SER)

  7. Serina Therapeutics Inc (SER) News

SER

Serina Therapeutics (SER)

Serina Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:SER
DatumZeitQuelleÜberschriftSymbolFirma
12/02/202522h15GlobeNewswire Inc.Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of DirectorsAMEX:SERSerina Therapeutics Inc
12/02/202522h04Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
03/02/202522h30GlobeNewswire Inc.Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsAMEX:SERSerina Therapeutics Inc
03/02/202522h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
03/02/202522h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:SERSerina Therapeutics Inc
15/01/202522h05GlobeNewswire Inc.Serina Therapeutics Announces Sale of UniverXome SubsidiaryAMEX:SERSerina Therapeutics Inc
14/01/202523h25GlobeNewswire Inc.Serina Therapeutics Welcomes Karen J. Wilson to its Board of DirectorsAMEX:SERSerina Therapeutics Inc
06/01/202522h07Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
18/12/202422h16Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
16/12/202412h00GlobeNewswire Inc.Serina Therapeutics to Present at Tribe Public’s Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024AMEX:SERSerina Therapeutics Inc
11/12/202412h05GlobeNewswire Inc.Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity SummitAMEX:SERSerina Therapeutics Inc
09/12/202422h45Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:SERSerina Therapeutics Inc
02/12/202423h22GlobeNewswire Inc.Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease PatientsAMEX:SERSerina Therapeutics Inc
02/12/202423h16Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
22/11/202422h15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:SERSerina Therapeutics Inc
12/11/202423h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
12/11/202423h00GlobeNewswire Inc.Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business HighlightsAMEX:SERSerina Therapeutics Inc
12/11/202422h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:SERSerina Therapeutics Inc
11/11/202423h40GlobeNewswire Inc.Serina Therapeutics Makes Grants to New Employees Under Inducement PlanAMEX:SERSerina Therapeutics Inc
06/11/202422h45Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:SERSerina Therapeutics Inc
06/11/202422h31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:SERSerina Therapeutics Inc
06/11/202412h32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:SERSerina Therapeutics Inc
01/11/202414h15Edgar (US Regulatory)Form DEFC14A - Definitive proxy statement, contested solicitationsAMEX:SERSerina Therapeutics Inc
02/10/202414h30Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
02/10/202414h30GlobeNewswire Inc.Serina Therapeutics to Present at the 14th Annual Injectables SummitAMEX:SERSerina Therapeutics Inc
17/09/202400h53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:SERSerina Therapeutics Inc
12/09/202423h17Edgar (US Regulatory)Form 8-K - Current reportAMEX:SERSerina Therapeutics Inc
05/09/202400h42GlobeNewswire Inc.Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAMEX:SERSerina Therapeutics Inc
23/08/202423h21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:SERSerina Therapeutics Inc
20/08/202400h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:SERSerina Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:SER

Kürzlich von Ihnen besucht

NASDAQ
IDLB
Invesco FTSE Internation...
BOV
IDFI11
Fundo DE Investimento Im...
NYSE
AT
Atlantic Power
AMEX
GII
SPDR S&P Global Infrastr...
LSE
XUKS
Xftse100 Sh Sw
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten